Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
SOURCE SonaCare Medical, LLC
CHARLOTTE, N.C., Feb. 19, 2014 /PRNewswire/ -- NYU Langone Medical Center and SonaCare Medical, LLC (SonaCare Medical), a global leader in minimally invasive focused therapeutic ultrasound technologies, announced a collaboration to develop tools and clinical procedures based on the use of advanced focused therapeutic ultrasound technology. Together, NYU Langone Medical Center and SonaCare Medical anticipate providing physician education, training and technology development across multiple disciplines.
"We are excited to be the first major medical center to acquire SonaCare Medical's new minimally invasive laparoscopic technology. This technology will add to the medical center's legacy of leadership and innovation in the field of minimally invasive therapies," said Andrew Brotman, MD, Senior Vice President and Vice Dean for Clinical Affairs and Strategy, Chief Clinical Officer.
According to Dr. Mark Carol, Chief Development Officer at SonaCare Medical, "The Sonatherm® laparoscopic surgical ablation system is a unique approach to soft tissue ablation that combines imaging, therapy, and dynamic robotic tracking capabilities that can be used in a wide variety of clinical conditions. It represents a direct extension of more than 40 years of focused therapeutic ultrasound experience at SonaCare Medical and represents the first step in an evolutionary process leading to 'Sound Medicine' – the use of images to guide a preplanned thermal procedure performed robotically on a wide variety of organs in the body."
"Every decade therapeutic medicine encounters a new device technology that enters the clinical arena and transforms the market, in large part because it is aligned with the defining characteristics of its time. Focused therapeutic ultrasound has the potential to be such a technology. It is well aligned with defining market characteristics that include migration from an organ-centric to a focal-centric disease orientation as well as a growing emphasis on image guided procedures. Together, we hope this collaboration will become a model for developing research-based, advanced clinical care delivery expertise in the use of focused therapeutic ultrasound and define a new set of surgical patterns of care and clinical protocols that will shape the future of many surgical specialties," said Mike Klein, CEO of SonaCare Medical.
About SonaCare Medical
SonaCare Medical, founded in 2004 and headquartered in Charlotte, N.C., is a privately held, venture-backed world leader in minimally invasive focused therapeutic ultrasound technologies. For additional information, visit www.SonaCareMedical.com.
©2012 PR Newswire. All Rights Reserved.